Other Common Ingredients: Weak Evidence, Strong Marketing Several other compounds appear regularly in GLP-1 supplement formulations, typically with minimal evidence for the specific claims made: Chromium Picolinate Marketed for insulin sensitivity and glucose metabolism, chromium shows weak and inconsistent evidence
by contrast, injection into the ARC increases glucose uptake in the BAT, with no effect on glucose uptake in the DMH or the PVH (Toda et al., 2009)
It is also linked to general cognitive decline of various forms, including memory problems, confusion, and compromised problem-solving ability
While supplementation may provide symptomatic benefits, an appropriate dosage has yet to be determined
Stay on the medication at the same or a reduced dose: There is no limit on the duration of GLP therapy
As a stable gastric pentadecapeptide, it has been widely studied as a tissue repair research peptide in structured experimental models evaluating extracellular matrix interaction and regenerative pathway research peptide mechanisms